Clinical Trial Update: A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 blinded trial for knee osteoarthritis was terminated; no results are provided in the available summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 2 | Status: TERMINATED